MDT
96.1
-0.44%↓
A
137.81
-0.48%↓
VEEV
224.76
+0.38%↑
HQY
92.67
-0.47%↓
PHR.US
16.99
-0.18%↓
MDT
96.1
-0.44%↓
A
137.81
-0.48%↓
VEEV
224.76
+0.38%↑
HQY
92.67
-0.47%↓
PHR.US
16.99
-0.18%↓
MDT
96.1
-0.44%↓
A
137.81
-0.48%↓
VEEV
224.76
+0.38%↑
HQY
92.67
-0.47%↓
PHR.US
16.99
-0.18%↓
MDT
96.1
-0.44%↓
A
137.81
-0.48%↓
VEEV
224.76
+0.38%↑
HQY
92.67
-0.47%↓
PHR.US
16.99
-0.18%↓
MDT
96.1
-0.44%↓
A
137.81
-0.48%↓
VEEV
224.76
+0.38%↑
HQY
92.67
-0.47%↓
PHR.US
16.99
-0.18%↓
24h
Corrente
Minimo
42.2
Massimo
44.51
Entrata | 6.1M -36M |
|---|---|
Vendite | 615K 12M |
EPS | -1.87 |
Margine di Profitto | -301.289 |
Dipendenti | 61 |
EBITDA | 6.9M -29M |
Raccomandazioni | Acquista |
|---|---|
Previsioni per 12 mesi | +133.11% upside |
Capitalizzazione di Mercato | -255M 884M |
|---|---|
Apertura precedente | 46.9 |
Chiusura precedente | 42.59 |
By Trading Central
Fiducia
Strong Bearish Evidence
0.5949 / 0.7406 Supporto e resistenza
Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.
29 dic 2025, 22:03 UTC
Mining Stocks Slip Near the End of Stellar Year
DJ
LeggI
29 dic 2025, 15:57 UTC
Praxis Shares Rise on Ulixacaltamide Breakthrough Designation
DJ
LeggI
29 dic 2025, 23:43 UTC
Nikkei May Decline; Yen in Focus -- Market Talk
DJ
LeggI
29 dic 2025, 23:38 UTC
Manus: Will Continue to Operate From Singapore
DJ
LeggI
29 dic 2025, 23:38 UTC
Manus: Will Continue to Sell, Operate Product Subscription Service Through App, Website
DJ
LeggI
29 dic 2025, 23:37 UTC
Meta Platforms: Will Integrate Manus Service Into Products
DJ
LeggI
29 dic 2025, 23:36 UTC
Meta Platforms: Will Continue to Operate, Sell Manus Service
DJ
LeggI
29 dic 2025, 23:36 UTC
Meta Platforms: Manus's Talent to Join Team to Deliver General-Purpose Agents Across Consumer, Business Products
DJ
LeggI
29 dic 2025, 23:35 UTC
Manus to Join Meta Platforms
DJ
LeggI
29 dic 2025, 21:33 UTC
Origin: Raise Values Kraken at US$8.65 Billion
DJ
LeggI
29 dic 2025, 21:33 UTC
Origin: Octopus Targeting Kraken Separation by Mid 2026
DJ
LeggI
29 dic 2025, 21:31 UTC
BlueScope: Rezoning Will Allow for Range of Commercial, Industrial Development Uses
DJ
LeggI
29 dic 2025, 21:31 UTC
BlueScope Also Says Land Adjacent to Port Kembla Steelworks Rezoned to Special Purpose
DJ
LeggI
29 dic 2025, 21:30 UTC
Origin's Kraken Stake to Remain at 22.7%
DJ
LeggI
29 dic 2025, 21:30 UTC
Origin Will Continue to Hold Its 22.7% Interest in Octopus
DJ
LeggI
29 dic 2025, 21:30 UTC
BlueScope: Guidance Reflects Sustained Strength of Operating Performance in Recent Months
DJ
LeggI
29 dic 2025, 21:30 UTC
Origin: Additional Interest Offsets Dilution From Raise
DJ
LeggI
29 dic 2025, 21:30 UTC
BlueScope Doesn't Expect Material Impact on 1H Guidance Range
DJ
LeggI
29 dic 2025, 21:29 UTC
Origin Waiving Australia Exclusivity to Kraken in Exchange for Additional 1.5% Equity Interest
DJ
LeggI
29 dic 2025, 21:29 UTC
BlueScope Expects to Complete Property Sale for A$76 Million Consideration
DJ
LeggI
29 dic 2025, 21:29 UTC
BlueScope Expects to Complete Property Sale in 2H of FY 2026
DJ
LeggI
29 dic 2025, 21:28 UTC
BlueScope: Selling Residentially Zoned Land in West Dapto to Large Homebuilder
DJ
LeggI
29 dic 2025, 21:28 UTC
Origin: Kraken's Raise Paves Way for Separation From Octopus Energy
DJ
LeggI
29 dic 2025, 21:28 UTC
Origin: Kraken to Raise Total US$1 Billion From New, Existing Investors
DJ
LeggI
29 dic 2025, 21:28 UTC
BlueScope Steel Exchanges Contracts for Sale of 33 Hectares of Land in West Dapto
DJ
LeggI
29 dic 2025, 21:27 UTC
Origin Energy to Invest US$140M in Kraken's Standalone Equity Raise
DJ
LeggI
29 dic 2025, 20:22 UTC
Oil Rebounds As Russia-Ukraine War Seen Continuing -- Market Talk
DJ
LeggI
29 dic 2025, 20:14 UTC
U.S. Natural Gas Futures Rise As Front Month Expires -- Market Talk
DJ
LeggI
29 dic 2025, 20:02 UTC
Union Pacific--Norfolk Southern Merger Targets Trucking Market Share -- Barrons.com
DJ
LeggI
29 dic 2025, 17:36 UTC
U.S. Natural Gas Inventories Swing to Deficit Vs. 5-Year Average -- Market Talk
DJ
LeggI
Modifica del prezzo
By TipRanks
Previsioni per 12 mesi
Media 103.71 USD 133.11%
Alto 135 USD
Basso 30 USD
Basato su 8 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Nektar Therapeutics - Dist negli ultimi 3 mesi.
By TipRanks
Acquista
8 ratings
6
Acquista
1
Mantieni
1
Vendi
Basato sugli analisti di 8 che hanno fornito valutazioni azionarie a Nektar Therapeutics - Dist negli ultimi 3 mesi.
By Trading Central
A breve termine
Strong Bearish Evidence
Recent bearish events outweigh bullish events.
A termine intermedio
Strong Bearish Evidence
All events are bearish.
A lungo termine
Bearish Evidence
All events are bearish.
Spese di vendita e di amministrazione
Spese operative
Utile prima delle imposte
Vendite
Costo delle vendite
Utile lordo sulle vendite
Interessi passivi sul debito
EBITDA
Utile operativo
$